Given investment horizon of 30 days, Salix Pharmaceuticals Ltd. is expected to generate 2.07 times more return on investment than Genpact. However, Salix is 2.07 times more volatile than Genpact Ltd.. It trades about 0.07 of its potential returns per unit of risk. Genpact Ltd. is currently generating about -0.04 per unit of risk. If you would invest 5,055 in Salix Pharmaceuticals Ltd. on April 26, 2012 and sell it today you would earn a total of 32.00 from holding Salix Pharmaceuticals Ltd. or generate 0.63% return on investment over 30 days.
Diversification
Good diversification
Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Genpact Ltd. in the same portfolio (assuming nothing else is changed)
97% of all equities and portfolios perform better than Salix Pharmaceuticals Ltd.. Compared with the overall equity markets, risk-adjusted returns on investments in Salix Pharmaceuticals Ltd. are ranked lower than 3 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
